Children's Mercy Hospital, Integrative Pain Management Clinic, Kansas City, Missouri.
Pain Manag Nurs. 2020 Oct;21(5):403-409. doi: 10.1016/j.pmn.2020.03.005. Epub 2020 May 21.
Chronic pain is a complex integration of biological, psychological, and social variables. Multidisciplinary pain management experts design interventions that treat the multidimensional experience. Children and adolescents with sickle cell disease (SCD) are at risk for chronic pain. Increased risk is associated with multiple characteristics including sickle cell genotype, age, gender, frequency of hospitalization, duration of hospitalization, and certain comorbid diagnoses. Referral to pain management professionals for this population is often delayed.
To increase multidisciplinary pain management referrals for youth with SCD identified to be at risk for chronic pain.
Implementation research.
One pediatric, academic medical facility serving as a regional sickle cell treatment center in the Midwest.
Children greater than 2 years of age and less than 21 years of age with laboratory confirmed SCD.
Implementation of an evidence-based screening tool using the consolidated framework for implementation research (CFIR) to guide project planning, design, and evaluation. The CFIR model was paired with the Plan-Do-Study-Act (PDSA) quality improvement methodology to operationalize workflow and sustain project aims.
Eighty-four percent of all eligible patients were screened during their routine sickle cell appointments resulting in a 110% increase in multidisciplinary pain management referrals. Future interventions and PDSA cycles are targeted at improving attendance at scheduled appointments, reducing hospitalizations, decreasing 30-day readmissions, and shortening length of stay.
慢性疼痛是生物、心理和社会变量的复杂综合。多学科疼痛管理专家设计的干预措施可以治疗多维体验。患有镰状细胞病 (SCD) 的儿童和青少年有发生慢性疼痛的风险。风险增加与多种特征有关,包括镰状细胞基因型、年龄、性别、住院频率、住院时间以及某些合并症诊断。该人群向疼痛管理专业人员的转介往往会延迟。
增加对有发生慢性疼痛风险的 SCD 青少年进行多学科疼痛管理的转介。
实施研究。
一家儿科学术医疗中心,作为中西部地区的镰状细胞治疗中心。
年龄大于 2 岁且小于 21 岁、经实验室确诊为 SCD 的儿童。
使用整合实施研究框架 (CFIR) 实施基于证据的筛选工具,以指导项目规划、设计和评估。CFIR 模型与计划-执行-研究-行动 (PDSA) 质量改进方法学相结合,以实现工作流程的实施和项目目标的维持。
在常规镰状细胞就诊期间对所有符合条件的患者进行了 84%的筛查,从而使多学科疼痛管理的转介增加了 110%。未来的干预措施和 PDSA 周期旨在提高预约的出勤率,减少住院,降低 30 天再入院率,并缩短住院时间。